E Fund Management Co., Ltd. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$253
-38.4%
26,982
+61.0%
0.02%
-40.6%
Q2 2023$411
+3.5%
16,762
-1.9%
0.03%
+10.3%
Q1 2023$397
-2.9%
17,081
+5.6%
0.03%
-14.7%
Q4 2022$409
-99.9%
16,178
-24.0%
0.03%
-10.5%
Q3 2022$410,000
-14.9%
21,284
+12.4%
0.04%
-13.6%
Q2 2022$482,000
+52.5%
18,939
+54.2%
0.04%
+340.0%
Q1 2022$316,00012,2830.01%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders